Skip to main content
Premium Trial:

Request an Annual Quote

Link Technologies Licenses Univ. of Manchester's Reagent Tech

NEW YORK (GenomeWeb News) – Link Technologies has licensed diagnostic reagent-related technology from the University of Manchester that it intends to market worldwide, the Scottish company said today.

Under the agreement with the University of Manchester Intellectual Property Limited, the firm acquired the rights to make and sell oligonucleotide reagents using the university's exciplex technology. It also will collaborate with the university to further develop the existing technology.

Link Technologies said the license covers exciplex diagnostic probes based on labeling oligonucleotides with exciplex partners that form excited-state complexes in close spatial proximity. It said that the technology offers increased specificity and detection sensitivity over conventional systems due to a lower signal-to-noise ratio.

Using such modified oligonucleotides in diagnostic systems has been shown to discriminate DNA mutations at the level of PCR products and plasmid DNA, the company said.

"Our ongoing collaboration with the university over the coming months will optimize the technology, allowing Link to launch a new range of innovative products targeted at diagnostic companies worldwide," Link Technologies' Business Development Director John Bremner said in a statement.

Financial terms of the agreement were not released.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.